SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SRRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Krystal Biotech, Inc. 114.19M
Stoke Therapeutics, Inc. 67.09M
Biogen, Inc. 2.468B
Eli Lilly & Co. 11.56B
Apellis Pharmaceuticals, Inc. 550.26M